Plain-English translation of NCT05365009 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a research registry—a long-term health tracking study—that follows patients with autoimmune interstitial lung disease (a group of serious lung conditions tied to the immune system) over five years. Researchers will gather information about your medical history, test results, imaging scans, medications, and how you're doing over time. The goal is to better understand how these diseases develop, which treatments help most, and what risks patients face.
Autoimmune lung diseases are complex and affect people differently. By collecting detailed information from many patients over several years, doctors hope to identify warning signs of disease progression, discover which treatments work best for different people, and ultimately improve care and survival for future patients.
You likely qualify if…
You likely don't qualify if…
You will have a baseline (starting) visit where doctors will review your medical history, test results, and current medications. Then you'll return once per year for follow-up appointments over five years, where researchers will check your lung function, review any new scans or blood work, and ask about how you're managing your disease and any side effects from treatment. The study is observational, meaning researchers are tracking your care and outcomes rather than asking you to take a new medication—they'll simply collect information about the treatments you're already receiving from your doctors.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
Argentina